TW0004743000
TW0004743000
ONENESS BIOTECH CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 23.06B EUR | 25.03B EUR | 24.98B EUR | 26.64B EUR |
Enterprise Value | 18.13B EUR | 25.02B EUR | 22.03B EUR | 25.36B EUR |
Valuation Multiples | ||||
Trailing P/E | 370x | 411.57x | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 149.98x | 162.76x | 177.73x | 256.43x |
Price to Book | 2.25x | 2.44x | 2.49x | 2.58x |
EV/Revenue | 117.89x | 162.7x | 156.79x | 244.03x |
EV/EBITDA | -35.69x | 61.07x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -0.99% | -0.78% | -1.95% | -1.65% |